These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 5005063)

  • 1. [Rifampicin in the intermittent treatment of experimental tuberculosis in mice].
    Lucchesi M; Matzeu M; Mancini P
    G Ital Mal Torace; 1971; 25(6):313-8. PubMed ID: 5005063
    [No Abstract]   [Full Text] [Related]  

  • 2. [Rifampicin and its sodium salt in experimental tuberculosis of albino mice].
    Pershin GN; Kutchek SN; Zykova TN
    Farmakol Toksikol; 1972; 35(3):342-7. PubMed ID: 4625834
    [No Abstract]   [Full Text] [Related]  

  • 3. [Investigation on failures in the treatment of pulmonary tuberculosis with rifampicin. Tuberculosis Research Committee. RYOKEN].
    Kekkaku; 1984 Feb; 59(2):91-104. PubMed ID: 6431172
    [No Abstract]   [Full Text] [Related]  

  • 4. Experimental and clinical studies of rifampicin in tuberculosis.
    Konno K; Oizumi K; Hayashi I; Oka S
    Sci Rep Res Inst Tohoku Univ Med; 1970 Dec; 17(3):110-20. PubMed ID: 5004309
    [No Abstract]   [Full Text] [Related]  

  • 5. [The sensitivity of Mycobacterium tuberculosis to rifampicin and its clinical effectiveness (author's transl)].
    Chen HL
    Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1980 Feb; 3(2):104-5. PubMed ID: 6774865
    [No Abstract]   [Full Text] [Related]  

  • 6. [Efficacy of rifampicin on experimental mouse tuberculosis].
    Yoshida F
    Jpn J Tuberc Chest Dis; 1970 Jul; 16(1):35-43. PubMed ID: 4990960
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effects of isoniazid and rifampicin on cell elements of cultured intact pulmonary tissue from experimental animals].
    Kunichan AD; Shapatava MN; Sokolova GB
    Probl Tuberk; 1991; (2):9-12. PubMed ID: 1903533
    [No Abstract]   [Full Text] [Related]  

  • 8. [Rifampicin and positive microscopic findings in a negative Mycobacterium tuberculosis culture].
    Begović N; Drinković I; Popović I
    Plucne Bolesti Tuberk; 1972; 24(3):157-62. PubMed ID: 4632836
    [No Abstract]   [Full Text] [Related]  

  • 9. The Australian rifampicin trial.
    Proust AJ
    Med J Aust; 1971 Jul; 2(2):85-94. PubMed ID: 4999365
    [No Abstract]   [Full Text] [Related]  

  • 10. [Experimental studies of the antimycobacterial activity of Rifampicine].
    Nitti V; Catena E; Ninni A; Di Filippo A
    Arch Tisiol Mal Appar Respir; 1966 Nov; 21(11):867-910. PubMed ID: 4969274
    [No Abstract]   [Full Text] [Related]  

  • 11. [Anti-mycobacterial activity of rifampicin].
    Gialdroni Grassi G
    G Ital Mal Torace; 1971; 25(2):77-88. PubMed ID: 5003253
    [No Abstract]   [Full Text] [Related]  

  • 12. [Experimental evidence for Mycobacterium tuberculosis persistence in M. tuberculosis-infected H37RV mice in the treatment with 3 first-line drugs (rifampicin, isoniazid, pyrazinamide)].
    Smirnova TG; Chernousova LN; Andreevskaia SN; Nikolaeva GM
    Probl Tuberk Bolezn Legk; 2004; (3):32-7. PubMed ID: 15338898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Intermittent rifampicine treatment of experimental tuberculosis. Morpho-pathological study (author's transl)].
    Diaconitza G; Lutzesco L
    Acta Tuberc Pneumol Belg; 1974; 65(2):228-42. PubMed ID: 4213882
    [No Abstract]   [Full Text] [Related]  

  • 14. [Results of intermittent treatment of tuberculosis and Mycobacteria shedding in children].
    Rudnik J; Majewska-Zalewska H
    Pediatr Pol; 1983 Dec; 58(12):941-55. PubMed ID: 6422437
    [No Abstract]   [Full Text] [Related]  

  • 15. Standardisation and evaluation of DNA-lanthanide fluorescence spectroscopy for determining rifampicin resistance in Mycobacterium tuberculosis clinical isolates.
    Mani C; Selvakumar N; Gajendiran N; Panigrahi B; Venkatesan P; Narayanan PR
    Int J Tuberc Lung Dis; 2003 Sep; 7(9):873-8. PubMed ID: 12971672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early bactericidal activity of high-dose rifampin in patients with pulmonary tuberculosis evidenced by positive sputum smears.
    Diacon AH; Patientia RF; Venter A; van Helden PD; Smith PJ; McIlleron H; Maritz JS; Donald PR
    Antimicrob Agents Chemother; 2007 Aug; 51(8):2994-6. PubMed ID: 17517849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapeutic effects of treatment with RFP on previously treated cases of pulmonary tuberculosis (author's transl)].
    Sakurai H; Watanabe Y; Yamanaka M; Moriguchi T; Fujii K; Uenoyama T
    Kekkaku; 1980 Nov; 55(11):485-91. PubMed ID: 6780716
    [No Abstract]   [Full Text] [Related]  

  • 18. [The pharmacokinetics of rifampicin in the intermittent treatment of patients with pulmonary tuberculosis. 2. The effect of rifampicin on the course of therapy for mycobacteriosis and non-tubercular infectious diseases].
    Eule H; Werner E; Winsel K; Iwainsky H
    Pharmazie; 1985 Apr; 40(4):276-7. PubMed ID: 4011667
    [No Abstract]   [Full Text] [Related]  

  • 19. [Note on a clinical trial of rifampicin in the treatment of pulmonary tuberculosis].
    Robustelli Pisani F
    G Ital Mal Torace; 1969; ():Suppl 2:85+. PubMed ID: 4982436
    [No Abstract]   [Full Text] [Related]  

  • 20. [Rifampicin in experimental tuberculosis].
    Kradolfer F
    Schweiz Med Wochenschr; 1968 Sep; 98(36):1363. PubMed ID: 5680480
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.